相关实验视频

Updated: Jun 18, 2025

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8⁺ T Cells During LN Metastasis

Published on: January 26, 2024

在淋巴瘤救援治疗上推出DICEP吗? 选择明智的选择

Monica Balzarotti¹, Filippo Bagnoli^1,2

¹Department of Oncology and Hematology, IRCCS Humanitas Research Hospital, Milan, Italy.

British journal of haematology

|July 29, 2024

概括

自主干细胞移植对于复发性/耐药性扩散性大B细胞淋巴瘤至关重要. 正在评估R-DICEP和R-GDP等新型救援方案,以优化移植前治疗.

科学领域:

血液学血液学血液学
在瘤学瘤学.
临床试验临床试验

背景情况:

免疫疗法正在改变扩散性大B细胞淋巴瘤 (DLBCL) 治疗方法.
自主干细胞移植 (ASCT) 仍然是选择性DLBCL复发/耐药 (r/r) 患者的关键选择.
优化移植前阶段对于ASCT在r/rDLBCL中的成功至关重要.

研究的目的:

在R/RDLBCL患者中,在ASCT之前比较两种新型救援化疗方案的疗效和安全性.
为了评估Rituximab剂量密集型环胺,埃托波西德,西斯普拉丁 (R-DICEP) 与Rituximab-gemcitabine,德克萨米他,西斯普拉丁和cytarabine (R-GDP).

主要方法:

进行了一项随机的II期研究 (加拿大癌症试验小组LY.17).
在ASCT之前,患有r/r DLBCL的患者接受了R-DICEP或R-GDP作为救援疗法.
评估了包括响应率和移植相关毒性在内的结果.

主要成果:

无论是R-DICEP还是R-GDP,在r/r DLBCL的移植前环境中都表现出活性.
详细的疗效和安全数据比较这两种疗法是在斯图尔特等人研究中提出的.
该研究强调了所选择的救援方案对ASCT整体成功的重要性.

结论:

新型救援疗法在接受ASCT的r/rDLBCL患者的管理中发挥着重要作用.
诱导疗法的选择会影响进行自身干细胞移植的患者的结果.
进一步的研究可能会完善救援策略,以改善这种患者群体的治疗结果.

关键词:

DLBCL DLBCL 是一个字母.免疫疗法时代是免疫疗法时代.移植前阶段移植前阶段

更多相关视频

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Murine Superficial Lymph Node Surgery

Murine Superficial Lymph Node Surgery

Published on: May 21, 2012

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...